Dx Dialogues: The importance of comprehensive testing in oncology

Sanjay Juneja, MD, explains how comprehensive testing is helpful in identifying tumor-agnostic mutations.

Transcript

00:00

Recent multicenter studies show that comprehensive testing identifies actionable findings in a significant portion

00:06

of patients with advanced cancers. [CASUAL MUSIC]

00:13

So when we say advanced, we usually mean you're not going for curative intent. And when you do comprehensive testing,

00:19

you can get molecular features or mutations or targets that can increase your therapeutic options.

00:27

We finally have mutations that are called tumor-agnostic, meaning it doesn't even matter if it's found in a breast cancer versus a colon versus a pancreatic.

00:36

And you could potentially have a treatment if you have that mutation, regardless of the cancer type. This is what makes comprehensive profiling and molecular analysis

00:45

so important. When it comes to somatic testing, the guidelines even say for any stage IV cancer that they recommend comprehensive profiling

00:54

over single gene testing. [AUDIO LOGO]